Coral Gartner

A/Prof Coral Gartner

Associate Professor, School of Public Health, The University of Queensland

More from this expert

Clinical Articles iconClinical Articles

More than 2,000 people in the United States have developed serious lung damage in a poisoning outbreak associated with the use of vaping devices this year. At least 39 people have died from the condition.Most of those affected are young men. Their symptoms, which developed over a few days to several weeks, included cough, shortness of breath, chest pain, nausea, vomiting, abdominal pain, diarrhoea, fever, chills, and weight loss.The United States Centers for Disease Control and Prevention (CDC) has recently named this combination of symptoms – “e-cigarette or vaping product use associated lung injury”, or EVALI.Importantly, it has now implicated vitamin E acetate, an ingredient added to illicit cannabis vaping liquids, as the most likely cause of EVALI.

More than 2,000 people in the United States have developed serious lung damage in a poisoning outbreak associated with the use of vaping devices this year. At least 39 people have died from the condition.Most of those affected are young men. Their symptoms, which developed over a few days to several weeks, included cough, shortness of breath, chest pain, nausea, vomiting, abdominal pain, diarrhoea, fever, chills, and weight loss.The United States Centers for Disease Control and Prevention (CDC) has recently named this combination of symptoms – “e-cigarette or vaping product use associated lung injury”, or EVALI.Importantly, it has now implicated vitamin E acetate, an ingredient added to illicit cannabis vaping liquids, as the most likely cause of EVALI.

Clinical Articles iconClinical Articles

From October 1, new changes to Australian laws around vaping products should make it easier for adults to get low-dose nicotine vapes as a tool to quit smoking.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

Cardiovascular Risk and Fatty Liver Disease

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

A/Prof William Kemp

Gastroenterologist and Hepatologist; Alfred Hospital Melbourne, Monash University School of Translational Medicine

We invite you to our next free webcast, where I will discuss cardiovascular risk and fatty liver disease. Earn up to 4 hours CPD. RACGP & ACRRM accredited.